Full Breakdown
Senate Funding Bill Stalls Over Hemp-Derived THC Ban Delay
8/8/2026, 9:23:08 PM
Core Event
On July 31, 2026, the Senate voted 61-32 to table a bipartisan amendment introduced by Sen. Ted Budd (R-N.C.) that would have stripped a provision delaying the federal ban on most hemp-derived THC products. The provision, inserted at the White House’s request, pushes the ban’s effective date from November 12 to December 11. With the amendment defeated, the ban will take effect on the original schedule after a one-month extension built into the continuing resolution that funds the government through December.
Background & Context
The 2018 Farm Bill removed hemp from the controlled-substances list, defining legal hemp as containing no more than 0.3 % delta-9 THC. Companies later engineered “intoxicating” hemp products—gummies, vapes, and drinks—that stay within the definition but deliver a marijuana-like high. In late 2025 Congress redefined hemp to limit total THC to 0.4 mg per container, effectively closing the “hemp loophole.” President Donald Trump signed that ban into law as part of a spending package that reopened the government after a record shutdown.
Timeline
- November 12 – Original date for the hemp-derived THC ban to take effect.
- December 11 – Date to which the ban is delayed by the continuing resolution.
- July 31, 2026 – Senate votes to table Budd’s amendment, allowing the delay to remain.
- August 5, 2026 – Media outlets publish detailed accounts of the intra-party fight.
Data & Statistics
- The intoxicating hemp industry was valued at more than $28 billion last year, supporting 300,000 jobs and generating $1.5 billion in state tax revenue.
- Pediatric cannabis-related emergency-room visits have surged, with a 461 % increase reported by the New York Times and a 969 % rise cited by the News Observer in North Carolina between 2017 and 2025.
Official Statements & Responses
- Kush Desai, White House spokesman, said, “The Chief of Staff has never lobbied in favor of this or any other position on hemp with Capitol Hill.”
- Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, warned that removing the delay would “undo significant gains” for seniors and disabled Americans who rely on a CMS pilot program to obtain full-spectrum CBD.
On-the-Ground Reports
Amy Yanzer, co-owner of Forward Beverage Co. in Wisconsin, said the pending delay forces her to pivot away from hemp-derived THC drinks toward non-cannabis alternatives.
Conflicting Reports & Gaps
- Pediatric poisoning statistics differ sharply: a 461 % increase reported by the New York Times versus a 969 % increase cited by the News Observer. Both sources agree the trend is upward but provide divergent magnitudes.
- Industry groups claim the one-month extension will enable “responsible regulation,” yet no concrete legislative timetable has been presented.
What’s Next
The continuing resolution must still pass the House before President Trump can sign it. Lawmakers have indicated that the delay provision could be revisited in a future appropriations bill, but no specific deadline has been set. The debate is expected to resurface after the August recess, with industry advocates and child-safety groups preparing additional lobbying efforts.
